Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wong

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|February 21, 2023
Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8Laura F Mataseje, Florence Doualla-Bell, David A Boyd, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman PrimatesSean P Brown, Paul Dransfield, Marc Vimolratana, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2026
Ketone reduction drives major circulating metabolites of GDC-8264 in humansShuai Wang, Susan Wong, Antonio DiPasquale, et al.
Nature Biotechnology|October 15, 2020
Author Correction: Multiplexed droplet single-cell RNA-sequencing using natural genetic variationHyun Min Kang, Meena Subramaniam, Sasha Targ, et al.
Nature Biotechnology|December 12, 2017
Multiplexed droplet single-cell RNA-sequencing using natural genetic variationHyun Min Kang, Meena Subramaniam, Sasha Targ, et al.
International Journal of Cancer|August 24, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerAntoinette S Perry, Gillian O'Hurley, Omer A Raheem, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Synthesis and SAR study of potent and selective PI3Kδ inhibitorsMinna Bui, Xiaolin Hao, Youngsook Shin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Microbial Drug Resistance (Larchmont, N.Y.)|February 21, 2023
Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8Laura F Mataseje, Florence Doualla-Bell, David A Boyd, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman PrimatesSean P Brown, Paul Dransfield, Marc Vimolratana, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2026
Ketone reduction drives major circulating metabolites of GDC-8264 in humansShuai Wang, Susan Wong, Antonio DiPasquale, et al.
Nature Biotechnology|October 15, 2020
Author Correction: Multiplexed droplet single-cell RNA-sequencing using natural genetic variationHyun Min Kang, Meena Subramaniam, Sasha Targ, et al.
Nature Biotechnology|December 12, 2017
Multiplexed droplet single-cell RNA-sequencing using natural genetic variationHyun Min Kang, Meena Subramaniam, Sasha Targ, et al.
International Journal of Cancer|August 24, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerAntoinette S Perry, Gillian O'Hurley, Omer A Raheem, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Synthesis and SAR study of potent and selective PI3Kδ inhibitorsMinna Bui, Xiaolin Hao, Youngsook Shin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
Pageof 7